"Rheumatic Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Disorders of connective tissue, especially the joints and related structures, characterized by inflammation, degeneration, or metabolic derangement.
| Descriptor ID |
D012216
|
| MeSH Number(s) |
C05.799 C17.300.775
|
| Concept/Terms |
Rheumatic Diseases- Rheumatic Diseases
- Disease, Rheumatic
- Diseases, Rheumatic
- Rheumatic Disease
- Rheumatism
|
Below are MeSH descriptors whose meaning is more general than "Rheumatic Diseases".
Below are MeSH descriptors whose meaning is more specific than "Rheumatic Diseases".
This graph shows the total number of publications written about "Rheumatic Diseases" by people in this website by year, and whether "Rheumatic Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 2 | 0 | 2 |
| 1999 | 1 | 0 | 1 |
| 2002 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 2 | 0 | 2 |
| 2008 | 0 | 1 | 1 |
| 2009 | 2 | 0 | 2 |
| 2011 | 2 | 0 | 2 |
| 2013 | 2 | 1 | 3 |
| 2014 | 6 | 3 | 9 |
| 2015 | 1 | 0 | 1 |
| 2017 | 4 | 2 | 6 |
| 2018 | 1 | 0 | 1 |
| 2019 | 9 | 0 | 9 |
| 2021 | 4 | 0 | 4 |
| 2022 | 2 | 0 | 2 |
| 2023 | 3 | 0 | 3 |
| 2024 | 5 | 1 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Rheumatic Diseases" by people in Profiles.
-
Emapalumab Treatment in Patients With Rheumatologic Disease-Associated Hemophagocytic Lymphohistiocytosis in the United States: A Retrospective Medical Chart Review Study. Arthritis Rheumatol. 2025 Feb; 77(2):226-238.
-
2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases. Arthritis Rheumatol. 2024 Aug; 76(8):1201-1213.
-
2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases. Arthritis Care Res (Hoboken). 2024 08; 76(8):1070-1082.
-
2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases. Arthritis Care Res (Hoboken). 2024 08; 76(8):1051-1069.
-
2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases. Arthritis Rheumatol. 2024 Aug; 76(8):1182-1200.
-
Opioid Treatment for Adults With and Without Systemic Autoimmune/Inflammatory Rheumatic Diseases: Analysis of 2006-2019 United States National Data. Arthritis Care Res (Hoboken). 2024 10; 76(10):1427-1435.
-
Rheumatic adverse events of immune checkpoint inhibitors in cancer immunotherapy. Expert Rev Clin Immunol. 2024 Aug; 20(8):873-893.
-
Patient Voices in Rheumatic Immune-related Adverse Events. Rheum Dis Clin North Am. 2024 05; 50(2):241-254.
-
OMERACT Core outcome measurement set for shared decision making in rheumatic and musculoskeletal conditions: a scoping review to identify candidate instruments. Semin Arthritis Rheum. 2024 Apr; 65:152344.
-
Improved lung cancer clinical outcomes in patients with autoimmune rheumatic diseases. RMD Open. 2023 10; 9(4).